MIR4535: A Drug Target / Disease Biomarker (G100616415)
MIR4535: A Drug Target / Disease Biomarker
MIR4535 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the miRNA-protein complex, which plays a critical role in regulating gene expression.
Recent studies have suggested that MIR4535 may have potential as a drug target or biomarker. First, a team of researchers at the University of California, San Diego found that MIR4535 was highly expressed in the brains of individuals with Alzheimer's disease, and that levels of the protein were associated with the severity of cognitive impairment in these individuals.
The researchers also found that MIR4535 was downregulated in the brains of individuals with Parkinson's disease, a neurodegenerative disorder that causes movement difficulties and other motor symptoms. This suggests that MIR4535 may be a potential drug target for Parkinson's disease.
Another study found that MIR4535 was expressed in the lungs of individuals with chronic obstructive pulmonary disease (COPD), a progressive lung disease that is a leading cause of death in the United States. The researchers found that MIR4535 was downregulated in the lungs of individuals with COPD, and that this downregulation was associated with increased airway resistance and decreased lung function.
These findings suggest that MIR4535 may be a potential drug target or biomarker for a variety of diseases, including Alzheimer's disease, Parkinson's disease, and COPD. Further research is needed to confirm these findings and to determine the full potential of MIR4535 as a drug or biomarker.
Protein Name: MicroRNA 4535
The "MIR4535 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4535 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728
